PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC

NCT07697859 · clinicaltrials.gov ↗

RECRUITING

Status

354

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)

Interventions

OTHER: Two arms adopt local intervention administered at distinct timings.

Sponsor

Fudan University